Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Regular, predictable dosing helps maintain stable medication levels in your bloodstream, which translates to more consistent blood glucose control, reduced side effects, and better long-term management of type 2 diabetes
The FDA approved Opdivo Qvantig, a subcutaneous formulation of the drug, in early 2025, improving patient convenience and potentially expanding its market share
If retatrutide is unavailable, cost-prohibitive, or contraindicated in your case, PlexusDx compounded semaglutide ($189/mo) and tirzepatide ($289/mo injection, $349/mo oral) offer lower-cost, well-established alternatives that may align with your genetic and biomarker profile
This dual effect on appetite regulation and glucose metabolism makes them effective for both weight loss and type 2 diabetes management
6 BradleyD.ConteC.MittendorferB.EagonJ
US$ 27.54
US$ 29.32
US$ 28.70
US$ 26.29
US$ 22.83
